Scientists identify a septic shock susceptibility geneNovember 03, 2006In the November 15th issue of G&D, Dr. Robert Schneider and colleagues at NYU School of Medicine report that the AUF1 gene underlies susceptibility to septic shock. Septic shock often follows a bacterial infection, and is characterized by the overwhelming release of pro-inflammatory cytokines by the body's immune system. This uncontrolled, systemic inflammatory response leads to dangerously low blood pressure and, ultimately, organ failure. One quarter to one half of sepsis patients die, making it the leading cause of hospital deaths in the US. Dr. Schneider and colleagues demonstrate that the protein encoded by the AUF1 gene destabilizes the mRNA precursors of important pro-inflammatory cytokines. To better understand the role of AUF1 in septic shock, the scientists engineered a strain of transgenic mice deficient in the AUF1 gene, and then exposed them to bacterial endotoxin.
Dr. Schneider and colleagues observed that AUF1-deficinet mice were more sensitive to endotoxin-induced septic shock, displaying an exacerbated pro-inflammatory response and higher mortality rates. They found that AUF1 normally attenuates the immune response by limiting expression of two specific cytokines - TNFalpha and IL-1beta. In fact, treatment of AUF1-deficient mice with antibodies to neutralize TNFalpha and IL-1beta effectively combated endotoxic shock. Further research is needed to delineate precisely how AUF1 regulates TNFalpha and IL-1beta, but Dr. Schneider is confident that "AUF1 is a key factor involved in septic shock, and its identification provides an important new target for development of agents to reduce mortality from this life-threatening condition." Cold Spring Harbor Laboratory | |||||||||||||||||||||
|
Related Septic Shock Current Events and Septic Shock News Articles Mathematical models of adaptive immunity More than five million people die every year from infectious diseases, despite the availability of numerous antibiotics and vaccines. The balance shifts The risk of contracting a Clostridium difficile infection following operations for which a "prophylactic" antibiotic is given to prevent infection is 21 times greater now than it was just a decade ago, according to researchers from the University of Sherbrooke in Canada. They report their findings in the June 15 issue of Clinical Infectious Diseases, currently available online. Customized treatments for sepsis lower treatment time and reduce length of ICU stays Using a blood test and a decision algorithm, rather than standard hospital protocols, to determine the appropriate length of antibiotic therapy in patients with severe sepsis or septic shock can reduce duration of treatments, shorten ICU stays, and lower hospital costs- all without adverse effects on patients, according to new research. Scripps scientists studying sepsis in mice find potential drug targets for deadly disease "We have identified a key connection of signaling pathways in the cascade of events leading to sepsis. This defines a crucial point where the immune system spirals out of control to cause severe sepsis and where there is an opportunity for therapeutic intervention," says Scripps Research Professor Wolfram Ruf, who led the research with his postdoctoral fellow Frank Niessen. Chicken pox vaccination should be introduced for children in the UK The only realistic way of preventing deaths and severe complications arising from chickenpox is to routinely vaccinate children against the disease, concludes research published ahead of print in Archives of Disease in Childhood. Gene expression pattern could lead to improved treatment of pediatric septic shock A consortium of researchers headed by Cincinnati Children's Hospital Medical Center has discovered a gene expression pattern that could lead to improved diagnosis and treatment of pediatric septic shock - still a serious public health problem despite today's potent antibiotics and pediatric intensive care units. Protocol for treatment of sepsis can reduce hospital deaths More than 215,000 people will die of sepsis in the United States each year, more than 750,000 will require hospital treatment, and the costs will be nearly $17 billion. Continuous infusion of hydrocortisone reduces hyperglyaemia in patients with septic shock Changing how critically ill patients are treated with hydrocortisone could reduce hyperglycemia. New approach could lower antibiotic requirements by 50 times Steven Hagens, previously at the University of Vienna, told Chemistry & Industry, the magazine of the SCI, that certain bacteriophages, a type of virus that infects bacteria, can boost the effectiveness of antibiotics gentamicin, gramacidin or tetracycline. New approach could lower antibiotic requirements by 50 times Antibiotic doses could be reduced by up to 50 times using a new approach based on bacteriophages. More Septic Shock Current Events and Septic Shock News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||